Biotechnology Stocks II Performance Guide: ARS Pharmaceuticals, Inc. (SPRY)
SPRY has no dividends.
Table and Chart of SPRY Performance
See what a $1,000 investment in SPRY is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| SPRY Returns | |
|---|---|
| Start Date | Jan-29-2021 |
| Start Price | $43.92 |
| End Date | May-16-2024 |
| End Price | $9.10 |
| # Prices | 41 |
| Min Date | Apr-29-2022 |
| Min Price | $3.11 |
| Max Date | Feb-26-2021 |
| Max Price | $48.06 |
| Total Return | -79.28% |
| Annualized Return | -36.92% |
| Current Value of $1,000 Purchase | $207 |
| Number Returns | 820 |
| Average Return | -12.79% |
| Number Profitable Returns | 324 |
| Percent Profitable Returns | 39.51% |
| Number Unprofitable Returns | 496 |
| Percent Unprofitable Returns | 60.49% |
| Profitable to Unprofitable Returns Ratio | 0.65 |
| SPRY Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $860,430,000 |
| Beta | Price to Sales | 29,014.82 |
| Earnings per Share | $-0.5200 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 3.768 |
| PRICE DATA | |
| 52 Week High | $11.27 |
| 52 Week Low | $2.55 |
| Analyst Target Price | $19 |
| 50-Day Moving Average | $9.04 |
| 200-Day Moving Average | $6.53 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $10,000 |
| Profit Margin | 0% |
| Return on Equity | -20.5% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
SPRY Compare Returns with S&P 500
SPRY Trendline Chart
SPRY Moving Average Chart
SPRY Stock Return Map - See Patterns of Gains and Losses
SPRY Stock Returns/Purchase Dates